Dear Esteemed Contributors, Authors, and Readers,

We hope this message finds you well. We are excited to reach out to the dedicated community of scholars, researchers, and professionals who have been integral to the success of The Journal of Heart Valve Disease.

As we embark on a new chapter with the resumption of our publication from the year 2023, we extend a heartfelt request for your continued support and active participation. The Journal of Heart Valve Disease has been a valuable platform for sharing groundbreaking research, fostering collaboration, and advancing the field of cardiovascular medicine.

How You Can Contribute:

1. Submit Your Research:
   We invite all existing contributors and authors, as well as new members of our community, to submit their latest research to The Journal of Heart Valve Disease. Your contributions play a vital role in enriching the scientific discourse and furthering our collective understanding of heart valve diseases.

2. Encourage Your Colleagues:
   Spread the word among your peers and colleagues about the resumption of our journal. Encourage them to share their expertise and findings by submitting their manuscripts. Together, we can create a vibrant and dynamic platform for knowledge exchange.

3. Peer Review Involvement:
   Consider becoming a peer reviewer for The Journal of Heart Valve Disease. Your expertise is invaluable in maintaining the quality and rigor of the research we publish. Join us in upholding the highest standards of scholarly review.

4. Engage as Readers:
   Stay engaged with The Journal of Heart Valve Disease by reading and citing the latest research published in our journal. Your readership is crucial in promoting the dissemination of knowledge and supporting the work of your fellow researchers.

The success of The Journal of Heart Valve Disease is built on the collective efforts of a dedicated community. Your contributions have made the journal a reputable source for cardiovascular research, and we are confident that together, we can continue to make significant strides in the field.

For manuscript submissions and additional information, please visit our website or contact our editorial office. We look forward to receiving your submissions and appreciate your ongoing commitment to advancing science and medicine through The Journal of Heart Valve Disease.

Thank you for being an essential part of our scholarly community.

Warm regards,

Editorial Team
The Journal of Heart Valve Disease

Dear Esteemed Scholars and Researchers,

We are thrilled to share with you a significant development regarding The Journal of Heart Valve Disease, a distinguished publication known for its commitment to excellence in cardiovascular research. After a temporary pause, we are delighted to announce the resumption of the journal's publication, starting from the year 2023.

In a move towards fostering inclusivity and advancing the accessibility of cutting-edge research, The Journal of Heart Valve Disease is proud to declare its transition to an open-access publication model. We believe that knowledge should be freely available to all, and to support this principle, we have eliminated Article Processing Charges (APCs) for authors.

Key Highlights:

1. Open Access Model:
   The Journal of Heart Valve Disease is now open access, ensuring that the wealth of knowledge disseminated through our platform is accessible to researchers, clinicians, and the wider scientific community worldwide.

2. No Article Processing Charges:
   Recognizing the financial constraints faced by researchers, we have decided to waive Article Processing Charges, allowing authors to submit their work without any cost barriers.

3. Invitation for Submissions:
   We extend a warm invitation to authors, researchers, and scholars to submit their original contributions to The Journal of Heart Valve Disease. Your valuable work will contribute to the journal's legacy of publishing high-quality research in the field of cardiovascular medicine.

4. PubMed Indexing:
   As a testament to the journal's academic standing, we are proud to share that more than 3500 papers from The Journal of Heart Valve Disease are currently indexed in PubMed. This achievement underscores the impact and significance of the research published in our journal.

This transition to open access aligns with our commitment to advancing science and facilitating the exchange of knowledge for the betterment of patient care and scientific understanding.

We express our gratitude to the scholarly community for your continued support and look forward to receiving your impactful contributions.

For manuscript submissions and additional details, please visit our updated website or contact our editorial office.

Thank you for being a part of The Journal of Heart Valve Disease's journey towards open and accessible scientific knowledge.

Sincerely,

Editorial Team
The Journal of Heart Valve Disease

editor@icr-heart.com